Home > Transtech Pharma Salary

Transtech Pharma Salary

  • 76
  • 92
  • 99
Transtech Pharma average salary is $185,000, median salary is $185,000 with a salary range from $170,000 to $200,000.
Transtech Pharma salaries are collected from government agencies and companies. Each salary is associated with a real job position. Transtech Pharma salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 2 Transtech Pharma Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Psychiatrist 170,000-170,000 Punxsutawney, PA, 15767 2012 Transtech Pharma Psychiatrist Salaries (1)
Transtech Pharma Punxsutawney, PA Salaries
Psychiatrist/medical Director 200,000-200,000 Indiana, PA, 15701 2012 Transtech Pharma Psychiatrist/medical Director Salaries (1)
Transtech Pharma Indiana, PA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Transtech Pharma salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Transtech Pharma Jobs
See more Transtech Pharma Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Transtech Pharma... Information
  • TransTech Pharma
  • Industry: BioTech/Drugs
  • City: High Point, NC
  • TransTech Pharma, Inc. is a privately held drug discovery company employing approximately 65 people. The Company's high-throughput drug discovery platform translates the wealth of information from genomics and proteomics into novel small molecules effective as therapeutics. TransTech intends to enter into additional collaborations for drug discovery and development with other leading biotechnology and pharmaceutical companies in addition to actively developing its own pipeline of small molecule drug candidates.